| answer text |
<p>No such assessment has been made. However, the majority of products supplied through
restricted wholesale models are branded medicines, for which prices are controlled
by the Pharmaceutical Price Regulation Scheme. The Department, Medicines and Healthcare
products Regulatory Agency, and pharmaceutical supply chain stakeholders agreed best
practice guidelines for dealing with supply and distribution of medicines. These set
out that where restricted wholesale models are in place, manufacturers should put
contingency arrangements in place so that pharmacies can obtain the product directly
from the manufacturer if they cannot get it from their wholesaler.</p>
|
 |
